Page 5 - Fibrogen China News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fibrogen china. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fibrogen China Today - Breaking & Trending Today

FibroGen, Inc. (NASDAQ:FGEN) Q2 2023 Earnings Call Transcript

FibroGen, Inc. (NASDAQ:FGEN) Q2 2023 Earnings Call Transcript August 7, 2023 Operator: Good day, and thank you for standing by. Welcome to the FibroGen’s Second Quarter 2023 Earnings Call. At this time, all participants are in listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s […] ....

United States , Djuan Graham , John Hunter , Fortis Therapeutics , Pet Imaging Agent , Fibrogen China , Morgan Stanley Tactical Value , Cancer Action Network , Span Can , Precision Promise , Artificial Intelligence Stocks Under , Pancreatic Cancer , John Hunter , Djuan Graham , Thane Wettig , Commercial Results ,

FibroGen, Inc. (NASDAQ:FGEN) Sees Large Increase in Short Interest

FibroGen, Inc. (NASDAQ:FGEN – Get Free Report) was the target of a significant growth in short interest in the month of June. As of June 30th, there was short interest totalling 7,870,000 shares, a growth of 18.9% from the June 15th total of 6,620,000 shares. Based on an average daily trading volume, of 2,160,000 shares, […] ....

United States , Enriquea Conterno , Raymond James , Stifel Nicolaus , Djuan Graham , William Blair , Vanguard Group Inc , Blackrock Inc , Fibrogen Inc , Hermes Inc , Securities Exchange Commission , Get Free Report , Exchange Commission , Street Corp , Federated Hermes , Fibrogen Daily , Nasdaq Fgen ,

FibroGen, Inc. (NASDAQ:FGEN) Short Interest Up 18.9% in June

FibroGen, Inc. (NASDAQ:FGEN – Get Free Report) was the target of a significant increase in short interest in June. As of June 30th, there was short interest totalling 7,870,000 shares, an increase of 18.9% from the June 15th total of 6,620,000 shares. Approximately 8.8% of the shares of the stock are sold short. Based on […] ....

United States , Enriquea Conterno , William Blair , Djuan Graham , Raymond James , Stifel Nicolaus , Us Capital Wealth Advisors , Altshuler Shaham Ltd , Securities Exchange Commission , Tower Research Capital , Royal Bank , Fibrogen Inc , Get Free Report , Gen Stock Down , Exchange Commission , Shaham Ltd , Forest Capital Management , Research Capital , Wealth Advisors , Fibrogen Daily , Nasdaq Fgen ,

FibroGen (NASDAQ:FGEN) Downgraded by Raymond James

Raymond James downgraded shares of FibroGen (NASDAQ:FGEN – Free Report) from an outperform rating to a market perform rating in a research note published on Monday morning, The Fly reports. FGEN has been the subject of several other reports. William Blair cut FibroGen from an outperform rating to a market perform rating in a research […] ....

Raymond James , Christine Chung , Stifel Nicolaus , Mark Eisner , William Blair , Metlife Investment Management , Panagora Asset Management Inc , York Mellon Corp , Dimensional Fund Advisors , Fibrogen Inc , Fibrogen Company Profile , Securities Exchange Commission , Alphacrest Capital Management , Free Report , Exchange Commission , New York Mellon Corp , Crest Capital Management , Life Investment Management , Asset Management , Fund Advisors , Fibrogen Daily , Nasdaq Fgen ,

FibroGen (NASDAQ:FGEN) Downgraded by Stifel Nicolaus

FibroGen (NASDAQ:FGEN – Get Rating) was downgraded by investment analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating in a research report issued on Monday, The Fly reports. FGEN has been the topic of a number of other research reports. Bank of America cut shares of FibroGen from a “buy” rating to […] ....

United States , Djuan Graham , Stifel Nicolaus , William Blair , Christine Chung , Raymond James , Royal Bank , Fibrogen Company Profile , Altshuler Shaham Ltd , Us Capital Wealth Advisors , Fibrogen Inc , Securities Exchange Commission , Get Rating , Gen Trading Down , Exchange Commission , Shaham Ltd , Forest Capital Management , Wealth Advisors , Fibrogen Daily , Nasdaq Fgen ,